The following is the text of a letter sent to the New Jersey Department of Education from the Robin Lipman, chairperson of ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...

The full text of the letter follows: As we reflect on 2024 ... that a woman will develop breast cancer in her lifetime. This achievement highlights (Z)-endoxifen’s potential as a promising ...

This achievement highlights (Z)-endoxifen’s potential as a promising therapy for women with dense breast tissue, offering a safer, better tolerated alternative to tamoxifen. By ...

This achievement highlights (Z)-endoxifen’s potential as a promising therapy for women with dense breast tissue, offering a safer, better tolerated alternative to tamoxifen. By reducing MBD ...

As we reflect on 2024, I am proud to share the remarkable progress Atossa Therapeutics has made in advancing our mission to address significant unmet needs in breast cancer prevention and ...

17) accuses the former president of “self-adulation” for his “supposed” accomplishments. Yet some of the pardons and commutations granted by Joe Biden are to protect those whom President ...